Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
35.98
+0.23 (+0.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harmony Biosciences Holdings Inc
< Previous
1
2
3
4
5
6
7
Next >
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
August 14, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
August 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
August 14, 2023
With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications.
Via
InvestorPlace
The Latest Analyst Ratings for Harmony Biosciences
August 01, 2023
Via
Benzinga
Harmony Biosciences's Earnings Outlook
July 31, 2023
Via
Benzinga
Analyst Expectations for Harmony Biosciences's Future
June 23, 2023
Via
Benzinga
Harmony Biosciences Earnings Perspective: Return On Capital Employed
May 08, 2023
Via
Benzinga
Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals
August 14, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
August 14, 2023
Via
Benzinga
Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today?
August 14, 2023
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares are skyrocketing Monday after Harmony Biosciences (NASDAQ: HRMY) announced it will
Via
Benzinga
7 ‘Strong Buy’ Value Stocks You Should Be Loading Up On Now
August 03, 2023
Although ultra-cheap ideas tend to carry significant risks, these strong buy value stocks offer the endorsement of analysts.
Via
InvestorPlace
Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript
August 01, 2023
HRMY earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
August 01, 2023
From
Harmony Biosciences
Via
GlobeNewswire
Analyst Expectations for Harmony Biosciences's Future
May 03, 2023
Via
Benzinga
Earnings Outlook For Harmony Biosciences
May 01, 2023
Via
Benzinga
Analyst Ratings for Harmony Biosciences
April 17, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 24, 2023
Via
Benzinga
7 Best High-Growth Stocks to Buy if You’re a Young Investor
June 29, 2023
If you’re just starting out and have plenty of time to work with, these are the high-growth stocks for young investors.
Via
InvestorPlace
3 Biotech Stocks to Buy With Explosive Upside Potential
June 22, 2023
These three biotech stocks with high upside potential also display some significant risk, but less so than many of their small-cap peers.
Via
InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm
June 19, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript
May 02, 2023
HRMY earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
May 02, 2023
From
Harmony Biosciences
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
April 23, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
7 Stocks to Buy to Bag Big-Time Returns in Q2
April 16, 2023
If you’re willing to take huge risks, these stocks to buy might yield you massive gains in Q2 – or you could be looking at a tax write-off.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
April 20, 2023
Via
Benzinga
NASDAQ:HRMY Shareholder Alert: Investigation over Possible Securities Laws Violations by Harmony Biosciences Holdings, Inc.
April 14, 2023
San Diego, CA -- (SBWIRE) -- 04/14/2023 -- An investigation was announced for investors of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) shares over potential securities laws violations by Harmony...
Via
SBWire
Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
April 12, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months
April 12, 2023
Recent, positive clinical data released by Novavax (NVAX) indicates that NVAX stock could surge almost 12 times in the next year.
Via
InvestorPlace
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
Via
InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Nutanix and Harmony and Encourages Investors to Contact the Firm
April 02, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.